Acute Ischemic Stroke Archives

Biogen Acquires Investigational Drug for Acute Ischemic Stroke

Acquisitions, Acute Ischemic Stroke, Biogen, Business, Clinical Data, Clinical Trials, R&D, Thrombolytic agents

Biogen Inc. exercised the company’s option to acquire TMS-007, an investigational drug for acute ischemic stroke, from TMS Co. Ltd.

Brilinta Decreases Risk of New Stroke Events After Stroke or TIA

Acute Ischemic Stroke, Analysis, Aspirin, Clinical Trial Endpoints, Clinical Trials, Data, Death Rates, P2Y12 Receptor Antagonists, R&D, Therapeutics, Transient Ischemic Attack (TIA)

AstraZeneca released positive data from the Phase III THALES trial of Brilinta (ticagrelor) used twice a day with an aspirin.

NoNO’s Stroke Trial Could Have Major Implications for Future Treatment

Acute Ischemic Stroke, Clinical Trials, Endovascular Thrombectomy, Neurons, R&D, The Lancet, Thrombectomy

Toronto-based NoNO Inc. announced results from the pivotal Phase III ESCAPE-NA1 trial of intravenous nerinetide in patients with acute ischemic stroke who were chosen to undergo endovascular thrombectomy.